A reversible concentrating defect in predominantly unilateral renal Hodgkin's disease.
D000328:Adult; D000618:Aminohippuric Acids / Q000652:urine; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001769:Blood; D001806:Blood Urea Nitrogen; D005919:Glomerular Filtration Rate; D006689:Hodgkin Disease / Q000503:physiopathology*; D006801:Humans; D007668:Kidney / Q000473:pathology; D007671:Kidney Concentrating Ability; D007680:Kidney Neoplasms / Q000503:physiopathology*; D008297:Male; D009994:Osmolar Concentration; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D011704:Pyelonephritis / Q000503:physiopathology; D012964:Sodium / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014556:Urine; D014567:Urography; D014750:Vincristine / Q000627:therapeutic use
D000618:Aminohippuric Acids; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D014527:Uric Acid; D010758:Phosphorus; D014750:Vincristine; D012964:Sodium; D011188:Potassium; D011241:Prednisone